Stromal composition predicts recurrence of early rectal cancer after local excision by Jones, H, Cunningham, C, Askautrud, H, Danielsen, H, Kerr, D, Domingo, E, Maughan, TIM, Koelzer, V

IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling by Sheng, X, Nenseth, H, Qu, S, Kuzu, O, Frahnow, T, Simon, L, Greene, S, Zeng, Q, Fazli, L, Rennie, P, Mills, I, Danielsen, H, Theis, F, Patterson, J, Jin, Y, Saatcioglu, F

Use of multivariate analysis to suggest a new molecular classification of colorectal cancer. by Domingo, E, Ramamoorthy, R, Oukrif, D, Rosmarin, D, Presz, M, Wang, H, Pulker, H, Lockstone, H, Hveem, T, Cranston, T, Danielsen, H, Novelli, M, Davidson, B, Xu, Z, Molloy, P, Johnstone, E, Holmes, C, Midgley, R, Kerr, D, Sieber, O, Tomlinson, I

Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations by Mouradov, D, Domingo, E, Gibbs, P, Jorissen, R, Li, S, Soo, P, Lipton, L, Desai, J, Danielsen, H, Oukrif, D, Novelli, M, Yau, C, Holmes, C, Jones, I, McLaughlin, S, Molloy, P, Hawkins, N, Ward, R, Midgely, R, Kerr, D, Tomlinson, I, Sieber, O

Survival in stage II/III colorectal cancer is independently predicted by chromosomal and microsatellite instability, but not by specific driver mutations. by Mouradov, D, Domingo, E, Gibbs, P, Jorissen, R, Li, S, Soo, P, Lipton, L, Desai, J, Danielsen, H, Oukrif, D, Novelli, M, Yau, C, Holmes, C, Jones, I, McLaughlin, S, Molloy, P, Hawkins, N, Ward, R, Midgely, R, Kerr, D, Tomlinson, I, Sieber, O

BCL9L dysfunction impairs caspase-2 expression permitting aneuploidy tolerance in colorectal cancer. by López-García, C, Sansregret, L, Domingo, E, McGranahan, N, Hobor, S, Birkbak, N, Horswell, S, Grönroos, E, Favero, F, Rowan, A, Matthews, N, Begum, S, Phillimore, B, Burrell, R, Oukrif, D, Spencer-Dene, B, Kovac, M, Stamp, G, Stewart, A, Danielsen, H, Novelli, M, Tomlinson, I, Swanton, C

Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-bas... by Domingo, E, Camps, C, Kaisaki, P, Parsons, M, Mouradov, D, Pentony, M, Makino, S, Palmieri, M, Ward, R, Hawkins, N, Gibbs, P, Askautrud, H, Oukrif, D, Wang, H, Wood, J, Tomlinson, E, Bark, Y, Kaur, K, Johnstone, E, Palles, C, Church, D, Novelli, M, Danielsen, H, Sherlock, J, Kerr, D, Kerr, R, Sieber, O, Taylor, J, Tomlinson, I

Mutation burden and other molecular markers of prognosis in the QUASAR2 clinical trial of colorectal cancer treated with curative intent by Domingo, E, Camps, C, Kaisaki, P, Parsons, M, Mouradov, D, Pentony, M, Makino, S, Palmieri, M, Ward, R, Hawkins, N, Gibbs, P, Askautrud, H, Oukrif, D, Wang, H, Wood, J, Tomlinson, E, Bark, Y, Kaur, K, Johnstone, E, Palles, C, Church, D, Novelli, M, Danielsen, H, Sherlock, J, Kerr, D, Kerr, R, Sieber, O, Taylor, J, Tomlinson, I